183 related articles for article (PubMed ID: 35447500)
1. Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings.
Li D; Wang L; Cai W; Liang M; Ma X; Zhao X
Eur J Radiol; 2022 Jun; 151():110313. PubMed ID: 35447500
[TBL] [Abstract][Full Text] [Related]
2. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
5. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection.
Lee S; Kim SH; Park HK; Jang KT; Hwang JA; Kim S
Radiology; 2018 Aug; 288(2):456-466. PubMed ID: 29664340
[TBL] [Abstract][Full Text] [Related]
7. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
[TBL] [Abstract][Full Text] [Related]
8. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
9. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
[TBL] [Abstract][Full Text] [Related]
10. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract][Full Text] [Related]
11. Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram.
Xie T; Xie X; Liu W; Chen L; Liu K; Zhou Z
Eur Radiol; 2023 Nov; 33(11):7782-7793. PubMed ID: 37624415
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma.
Cheng CS; Liu W; Zhou L; Tang W; Zhong A; Meng Z; Chen L; Chen Z
Biomed Res Int; 2019; 2019():1356264. PubMed ID: 31886169
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy.
Yang HK; Park MS; Han K; Eom G; Chung YE; Choi JY; Bang S; Kang CM; Seong J; Kim MJ
Cancer Res Treat; 2024 Jan; 56(1):247-258. PubMed ID: 37605535
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
[TBL] [Abstract][Full Text] [Related]
15. Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery.
Dickinson SM; McIntyre CA; Schilsky JB; Harrington KA; Gerst SR; Flynn JR; Gonen M; Capanu M; Wong W; Lawrence S; Allen PJ; O'Reilly EM; Jarnagin WR; D'Angelica MI; Balachandran VP; Drebin JA; Kingham TP; Simpson AL; Do RK
Abdom Radiol (NY); 2021 Apr; 46(4):1607-1617. PubMed ID: 32986175
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification for overall survival and recurrence-free survival after R0 resection for solitary intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Eur J Radiol; 2023 Dec; 169():111190. PubMed ID: 37979460
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer.
Gao JF; Pan Y; Lin XC; Lu FC; Qiu DS; Liu JJ; Huang HG
World J Gastroenterol; 2022 Jun; 28(22):2468-2481. PubMed ID: 35979266
[TBL] [Abstract][Full Text] [Related]
19. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.
Tian N; Wu D; Zhu L; Zeng M; Li J; Wang X
BMC Med Imaging; 2022 Jul; 22(1):116. PubMed ID: 35786426
[TBL] [Abstract][Full Text] [Related]
20. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
